- Home
- NDLS vs COCH Comparison
NDLS vs COCH Comparison
Compare NDLS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NDLS | COCH |
|---|---|---|
| Founded | 1995 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 24.4M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | NDLS | COCH |
|---|---|---|
| Price | $0.64 | $0.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | ★ 748.8K | 434.7K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $494,087,000.00 | $208,000.00 |
| Revenue This Year | $2.18 | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $0.64 |
| 52 Week High | $1.74 | $2.00 |
Technical Indicators
Market Signals| Indicator | NDLS | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 40.95 | 39.00 |
| Support Level | $0.60 | $0.66 |
| Resistance Level | $0.80 | $0.77 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 7.85 | 21.43 |
Price Performance
Historical ComparisonAbout NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.